This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Author: Avi Kapoor | February 25, 2025 01:28pm
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Jefferies analyst Roger Song initiated coverage on Wave Life Sciences Ltd. (NASDAQ:WVE) with a Buy rating and announced a price target of $26. WAVE Life Sciences shares closed at $10.48 on Monday. See how other analysts view this stock.
TD Securities analyst Andrew Charles initiated coverage on Kura Sushi USA, Inc. (NASDAQ:KRUS) with a Hold rating and announced a price target of $72. Kura Sushi USA shares closed at $64.71 on Monday. See how other analysts view this stock.
Leerink Partners analyst Joseph Schwartz initiated coverage on Maze Therapeutics, Inc. (NASDAQ:MAZE) with an Outperform rating and announced a price target of $28. Maze Therapeutics shares closed at $10.82 on Monday. See how other analysts view this stock.
RBC Capital analyst Leonid Timashev initiated coverage on Insmed Incorporated (NASDAQ:INSM) with an Outperform rating and announced a price target of $100. Insmed shares closed at $80.03 on Monday. See how other analysts view this stock.
Keybanc analyst Tim Rezvan initiated coverage on Infinity Natural Resources, Inc. (NYSE:INR) with an Overweight rating and announced a price target of $26. Infinity shares closed at $19.13 on Monday. See how other analysts view this stock.
Considering buying INSM stock? Here’s what analysts think:
